Dr. Sterling Johnson is co-author of Policy View in upcoming issue of The Lancet Neurology. Recent tools of blood-based biomarker detection and improved understanding of risks could dramatically widen access to early detection and preclinical treatments, but the authors caution that affordability, health-insurance coverage, education, and clinical workflow integration are urgent priorities.
WAI News
Congratulations, Dr. Green-Harris!
Dr. Green-Harris’ current work is advising NIH efforts to incorporate community advisory board input into national study guidelines. In addition to her work at WAI, Dr. Green-Harris is also co-director of the Center for Health Partnerships and director of the Just Research program at University of Wisconsin School of Medicine and Public Health.
UW Alzheimer’s disease research highlighted at Fall Policy Forum
The event spotlighted advances in Alzheimer’s disease research at UW–Madison, with speakers Sanjay Asthana, MD; Cynthia Carlsson, MD, MS; and Sterling Johnson, PhD describing recent advancements in the field and the importance of continued support of the program.
Dr. Cynthia Carlsson discusses Swedish study about cheese and brain health
Carlsson said with the holidays here, it’s reassuring to know a little indulgence might not be so bad. However, she said, the study participants’ dietary patterns were not tracked throughout the study period, and it’s unclear if their other lifestyle practices may also play a role.
Wisconsin sports broadcasters raise voices for Initiative to End Alzheimer’s
Wisconsin radio broadcasters Paul Braun, Mike Heller, Matt Lepay, Jim Paschke and Brian Posick are teaming up to raise money and awareness for Alzheimer’s disease research at the University of Wisconsin–Madison.
Dr. Jessica Caldwell explores gender differences in Alzheimer’s disease as new WRAP study leader
Globally, Alzheimer’s disease impacts women at a much higher rate than men. In the United States, two-thirds of the 6.2 million people living with Alzheimer’s disease are women. Understanding these gender and sex differences – and ultimately preventing Alzheimer’s disease and related dementia – is at the root of the pioneering work of Jessica Caldwell, PhD, a new faculty member in the University of Wisconsin–Madison Alzheimer’s disease programs.
Latinos often face symptoms earlier, but are less likely to receive dementia diagnosis
In an interview on Telemundo Wisconsin, Maria Mora Pinzon, MD, MS, a physician and the implementation science leader at the Wisconsin Alzheimer’s Institute, shed light on the alarming disparities in dementia diagnosis and care affecting Latino communities. She described research which has found that although Latinos are disproportionately impacted by Alzheimer’s disease, they are the least likely to be informed of their diagnosis.
Thank you for joining us at Info Sessions!
That’s a wrap on our 2025 WRAP Info Sessions events. Thank you to the hundreds of participants who joined us in person for a Info Session event held in September and October in five locations in Wisconsin.
UW–Madison Alzheimer’s disease researchers present new findings at 2025 international conference
A team of researchers from the Wisconsin Alzheimer’s Institute joined nearly 19,000 global experts at the 2025 Alzheimer’s Association International Conference (AAIC), held July 27-July 31 in Toronto, Canada.
Two leading dementia researchers join UW–Madison
UW–Madison’s School of Medicine and Public Health is adding Henrik Zetterberg, a Swedish scientist who studies biomarkers, and Hartmuth Kolb, a German-born chemist and expert in imaging technology, to its faculty.